New Drugs

Brand/Generic Company Description
Cablivi
caplacizumab-yhdp
Click here for more information
Ablynx U.S.

A von Willebrand factor-directed antibody fragment for treatment of acquired thrombotic thrombocytopenic purpura (aTTP).

Egaten
triclabendazole
Click here for more information
Novartis

An oral anthelmintic for treatment of fascioliasis.

Herceptin Hylecta
trastuzumab/hyaluronidase-oysk
Click here for more information
Genentech

A subcutaneous injection formulation for HER2-overexpressing breast cancer.

Jeuveau
prabotulinumtoxin A-xvfs
Evolus

A botulinum toxin product to improve the appearance of frown lines between the eyebrows.

Ontruzant
trastuzumab-dttb
Merck

A biosimilar to Herceptin for breast cancer and gastric/gastroesophageal junction cancer.

Spravato
esketamine
Click here for more information
Janssen

An NMDA receptor antagonist nasal spray for treatment-resistant depression.

Brand/Generic Company Description
Adhansia XR
methylphenidate
Click here for more information
Purdue Pharma

New extended-release formulation for ADHD.

Gloperba
colchicine
Click here for more information
Romeg Therapeutics

A new oral solution formulation for prevention of gout flares in adults.

Lotemax SM
loteprednol etabonate
Click here for more information
Bausch + Lomb

New 0.38% steroid ophthalmic gel formulation to improve absorption. For post-op inflammation/pain following ocular surgery.

Tosymra
sumatriptan
Click here for more information
Promius Pharma

New 10 mg nasal spray formulation for acute migraine.

Brand/Generic Company Description